Hinova Pharmaceuticals, Inc. Class ASSE: 688302

Semi-annual Report in 2024

Aug 24, 2024 · Issued by Hinova Pharmaceuticals, Inc. Class A via Shanghai Stock Exchange

Semi-annual Report 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment